- Home
- AFBI vs CCCC Comparison
AFBI vs CCCC Comparison
Compare AFBI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFBI
- CCCC
- Stock Information
- Founded
- AFBI 1928
- CCCC 2015
- Country
- AFBI United States
- CCCC United States
- Employees
- AFBI N/A
- CCCC N/A
- Industry
- AFBI Major Banks
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- AFBI Finance
- CCCC Health Care
- Exchange
- AFBI Nasdaq
- CCCC Nasdaq
- Market Cap
- AFBI 117.2M
- CCCC 104.4M
- IPO Year
- AFBI N/A
- CCCC 2020
- Fundamental
- Price
- AFBI $19.00
- CCCC $2.46
- Analyst Decision
- AFBI
- CCCC Buy
- Analyst Count
- AFBI 0
- CCCC 2
- Target Price
- AFBI N/A
- CCCC $8.00
- AVG Volume (30 Days)
- AFBI 4.5K
- CCCC 1.5M
- Earning Date
- AFBI 07-25-2025
- CCCC 08-07-2025
- Dividend Yield
- AFBI 7.89%
- CCCC N/A
- EPS Growth
- AFBI 28.43
- CCCC N/A
- EPS
- AFBI 1.08
- CCCC N/A
- Revenue
- AFBI $31,417,000.00
- CCCC $34,240,000.00
- Revenue This Year
- AFBI N/A
- CCCC N/A
- Revenue Next Year
- AFBI N/A
- CCCC N/A
- P/E Ratio
- AFBI $17.62
- CCCC N/A
- Revenue Growth
- AFBI 4.20
- CCCC 16.55
- 52 Week Low
- AFBI $17.00
- CCCC $1.09
- 52 Week High
- AFBI $22.50
- CCCC $7.22
- Technical
- Relative Strength Index (RSI)
- AFBI 52.38
- CCCC 59.48
- Support Level
- AFBI $18.76
- CCCC $1.95
- Resistance Level
- AFBI $19.22
- CCCC $2.94
- Average True Range (ATR)
- AFBI 0.16
- CCCC 0.26
- MACD
- AFBI -0.02
- CCCC 0.00
- Stochastic Oscillator
- AFBI 41.67
- CCCC 51.52
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.